Lost money on anavex life sciences corp.(avxl)? you may have been affected by fraud- contact levi & korsinsky

New york, ny / accesswire / march 12, 2024 / levi & korsinsky notifies investors that it has commenced an investigation of anavex life sciences corp. ("anavex life sciences") (nasdaq:avxl) concerning possible violations of federal securities laws. on december 2, 2022, avxl announced positive topline results from its phase 2b/3 anavex®2-73-ad-004 clinical trial of oral anavex®2-73 (blarcamesine) for the treatment of mild cognitive impairment (mci) due to alzheimer's disease (ad) and mild ad (collectively known as early ad).
AVXL Ratings Summary
AVXL Quant Ranking